Effect of Atorvastatin Therapy on Fibrous Cap Thickness in Coronary Atherosclerotic Plaque as Assessed by Optical Coherence Tomography-Reference-Cited by-同舟云学术

Effect of Atorvastatin Therapy on Fibrous Cap Thickness in Coronary Atherosclerotic Plaque as Assessed by Optical Coherence Tomography

Published:2014-12 Issue:21 Volume:64 Page:2207-2217
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Komukai Kenichi,Kubo Takashi,Kitabata Hironori,Matsuo Yoshiki,Ozaki Yuichi,Takarada Shigeho,Okumoto Yasushi,Shiono Yasutsugu,Orii Makoto,Shimamura Kunihiro,Ueno Satoshi,Yamano Takashi,Tanimoto Takashi,Ino Yasushi,Yamaguchi Tomoyuki,Kumiko Hirata,Tanaka Atsushi,Imanishi Toshio,Akagi Hideharu,Akasaka Takashi

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference18 articles.

1. Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA);Sever;Lancet,2003

2. Intensive lipid lowering with atorvastatin in patients with stable coronary disease;LaRosa;N Engl J Med,2005

3. C-reactive protein levels and outcomes after statin therapy;Ridker;N Engl J Med,2005

4. Effect of intensive compared with moderate lipid-lowering therapy on progression of coronary atherosclerosis. A randomized controlled trial;Nissen;JAMA,2004

5. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study;Okazaki;Circulation,2004

Cited by 233 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Optical coherence tomography assessment of the impact of colchicine on non-culprit coronary plaque composition after myocardial infarction;Cardiovascular Research;2024-08-27

2. Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Patients Following Acute Coronary Syndromes: From Lipid Lowering and Plaque Stabilization to Improved Outcomes;Journal of Clinical Medicine;2024-08-25

3. Serial PET imaging to evaluate medical therapies: Is it ready for prime time?;Atherosclerosis;2024-08

4. One-year longitudinal changes of peripheral CD4+ T-lymphocyte counts, gut microbiome, and plaque vulnerability after an acute coronary syndrome;IJC Heart & Vasculature;2024-08

5. Thin-cap fibroatheroma: the trigger of acute coronary syndromes. Pathophysiological and prognostic importance of in-vivo detection.;International Journal of Cardiology;2024-08